Published in AIDS Weekly, November 8th, 1999
In two HIV infected patients treated with potent combinations of anti-HIV drugs and interleukin-2 (IL-2), and in whom even highly sensitive tests could detect no viable HIV, the virus quickly rebounded to substantial levels when therapy was stopped, according to researchers at the U.S. National Institute of Allergy and Infectious Diseases (NIAID).
NIAID director Anthony S. Fauci, MD, Tae-Wook Chun, PhD, and their colleagues reported their data in the October 28, 1999, issue of Nature.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.